# A Trial of Three- and Seven-days Insulin Infusions Set

> **NCT06532461** · NA · RECRUITING · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 80 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Mio Advanced infusions set
- **DRUG:** Novorapid
- **DEVICE:** Extended wear insulin infusion (EWIS)
- **DRUG:** Humalog

## Key facts

- **NCT ID:** NCT06532461
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06532461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06532461, "A Trial of Three- and Seven-days Insulin Infusions Set". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06532461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*